← Back to Clinical Trials
Recruiting NCT07124494

NCT07124494 Regional Anesthesia in TKA: Impact on Postoperative Joint Motion and Patient Satisfaction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07124494
Status Recruiting
Phase
Sponsor Konya City Hospital
Condition Total Knee Arthroplasty
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-08-05
Primary Completion 2026-02-12

Trial Parameters

Condition Total Knee Arthroplasty
Sponsor Konya City Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-08-05
Completion 2026-02-12
Interventions
Regional anethesia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a single-center, prospective, randomized controlled trial aiming to evaluate the effects of different regional anesthesia/analgesia techniques on postoperative knee range of motion (ROM) and patient satisfaction following total knee arthroplasty (TKA). Ninety patients undergoing elective TKA under spinal anesthesia will be randomly assigned to one of three groups: 1) spinal anesthesia with epidural catheter, 2) spinal anesthesia followed by adductor canal catheterization, and 3) spinal anesthesia with multimodal intravenous analgesia. The primary outcome is postoperative knee joint ROM measured on postoperative days 1, 2, and 3. Secondary outcomes include patient satisfaction, Oxford Knee Score, postoperative opioid consumption, and VAS scores. The study is conducted at Konya City Hospital and will be completed over a 6-month period.

Eligibility Criteria

* Minimum Age: 18 Years * Maximum Age: None * Sex: All * Gender Based: No * Accepts Healthy Volunteers: No * Inclusion Criteria: * Scheduled for primary total knee arthroplasty * Age ≥ 18 years * American Society of Anesthesiologists (ASA) physical status I-III * Accepting neuraxial anesthesia * Exclusion Criteria: * Skin infection at the planned injection site * Sepsis * Coagulopathy * Refusal of neuraxial anesthesia * Severe hypovolemia * Demyelinating central nervous system disease * Age under 18 years * Illiterate in Turkish * Non-cooperative patients * Known allergy or hypersensitivity to bupivacaine

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology